CCL5 and ovarian cancer: To gain mechanistic insight into this process, they observed that paracrine CCL5 from CD133+ ovarian cancer stem cells activated the NF-κB signaling pathway in CD133− cells via binding CCR1, CCR3 and CCR5, thereby inducing EMT and tumor invasion.